Literature DB >> 17848791

Histamine and the regulation of body weight.

Emilie A Jørgensen1, Ulrich Knigge, Jørgen Warberg, Andreas Kjaer.   

Abstract

Energy intake and expenditure is regulated by a complex interplay between peripheral and central factors. An exhaustive list of peptides and neurotransmitters taking part in this complex regulation of body weight exists. Among these is histamine, which acts as a central neurotransmitter. In the present article we review current evidence pointing at an important role of histamine in the regulation of appetite and metabolism. Studies using both knockout mouse models as well as pharmacological studies have revealed that histamine acts as an anorexigenic agent via stimulation of histamine H(1) receptors. One effect of histamine in the regulation of appetite is to act as a mediator of the inhibitory effect of leptin on appetite. It seems that histamine may attenuate and delay the development of leptin resistance in high-fat-diet-induced obesity. Furthermore, histamine may also act to accelerate lipolysis. Based on the current evidence of the involvement of histamine in the regulation of body weight, the histaminergic system is an obvious target for the development of pharmacological agents to control obesity. At present, H(3) receptor antagonists that stimulate the histaminergic system may be the most promising histaminergic drugs for antiobesity therapy. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17848791     DOI: 10.1159/000108341

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  19 in total

Review 1.  Structural features of mammalian histidine decarboxylase reveal the basis for specific inhibition.

Authors:  A A Moya-García; A Pino-Angeles; R Gil-Redondo; A Morreale; F Sánchez-Jiménez
Journal:  Br J Pharmacol       Date:  2009-05       Impact factor: 8.739

2.  The expression and function of histamine H₃ receptors in pancreatic beta cells.

Authors:  T Nakamura; T Yoshikawa; N Noguchi; A Sugawara; A Kasajima; H Sasano; K Yanai
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

3.  High levels of histidine decarboxylase in the striatum of mice and rats.

Authors:  Kuakarun Krusong; A Gulhan Ercan-Sencicek; Meiyu Xu; Hiroshi Ohtsu; George M Anderson; Matthew W State; Christopher Pittenger
Journal:  Neurosci Lett       Date:  2011-04-01       Impact factor: 3.046

Review 4.  Histamine receptor signaling in energy homeostasis.

Authors:  Iustin V Tabarean
Journal:  Neuropharmacology       Date:  2015-06-21       Impact factor: 5.250

Review 5.  Pharmacogenetics of leptin in antipsychotic-associated weight gain and obesity-related complications.

Authors:  Amy K Lee; Jeffrey R Bishop
Journal:  Pharmacogenomics       Date:  2011-07       Impact factor: 2.533

6.  High H1-affinity antidepressants and risk of metabolic syndrome in bipolar disorder.

Authors:  Virginio Salvi; Francesco Barone-Adesi; Virginia D'Ambrosio; Umberto Albert; Giuseppe Maina
Journal:  Psychopharmacology (Berl)       Date:  2015-09-26       Impact factor: 4.530

Review 7.  Atypical antipsychotics and effects on feeding: from mice to men.

Authors:  Louise Benarroch; Chantel Kowalchuk; Virginia Wilson; Celine Teo; Melanie Guenette; Araba Chintoh; Yasika Nesarajah; Valerie Taylor; Peter Selby; Paul Fletcher; Gary J Remington; Margaret K Hahn
Journal:  Psychopharmacology (Berl)       Date:  2016-06-01       Impact factor: 4.530

8.  Knockout of l-Histidine Decarboxylase Prevents Cholangiocyte Damage and Hepatic Fibrosis in Mice Subjected to High-Fat Diet Feeding via Disrupted Histamine/Leptin Signaling.

Authors:  Lindsey Kennedy; Laura Hargrove; Jennifer Demieville; Jennifer M Bailey; Wasim Dar; Kishore Polireddy; Qingzheng Chen; Moises I Nevah Rubin; Amelia Sybenga; Sharon DeMorrow; Fanyin Meng; Lindsey Stockton; Gianfranco Alpini; Heather Francis
Journal:  Am J Pathol       Date:  2017-12-15       Impact factor: 4.307

9.  Impact of preoperative body mass index on perioperative outcomes is optimized by enhanced recovery protocols in laparoscopic radical cystectomy with intracorporeal urinary diversion.

Authors:  Houyi Wei; Jiandong Gao; Mingshuai Wang; Wahafu Wasilijiang; Pan Ai; Xiaoguang Zhou; Liyan Cui; Liming Song; Anshi Wu; Nianzeng Xing; Yinong Niu
Journal:  Transl Androl Urol       Date:  2021-05

10.  Topiramate in the treatment of Prader-Willi syndrome: A case report.

Authors:  Nicole East; Megan Maroney
Journal:  Ment Health Clin       Date:  2018-03-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.